Announcements Trials

Browse Landscape

Phase

Status

Recruiting 6 Completed 6 Unknown 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 14 Neoplasms 11 Carcinoma, Non-Small-Cell Lung 10 Colorectal Neoplasms 9 Prostatic Neoplasms 8 Lung Neoplasms 7 Melanoma 6 Pancreatic Neoplasms 5 Neoplastic Cells, Circulating 4 Hematologic Neoplasms 4 Head and Neck Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Neoplasm Metastasis 3 Leukemia, Myeloid, Acute 3 Leukemia 3 Glioblastoma 3 Carcinoma, Hepatocellular 3 Uterine Cervical Neoplasms 2 Thyroid Neoplasms 2 Stomach Neoplasms 2 Sarcoma 2 Recurrence 2 Ovarian Neoplasms 2 Oropharyngeal Neoplasms 2 Myeloproliferative Disorders 2 Myelodysplastic Syndromes 2 Lymphoma, Non-Hodgkin 2 Liver Diseases 2 Kidney Neoplasms 2 Glioma 2

Interventions

Cyclophosphamide 36 Etoposide 25 Vincristine 24 Cytarabine 21 Doxorubicin 19 Rituximab 17 Radiotherapy 17 Peripheral Blood Stem Cell Transplantation 16 Melphalan 16 Prednisolone 14 Methotrexate 14 Filgrastim 13 fludarabine phosphate 11 Prednisone 11 Dexamethasone 11 Carmustine 9 Bleomycin 9 pegylated granulocyte colony-stimulating factor 8 Cyclosporine 8 Busulfan 8 Ifosfamide 7 Cisplatin 7 sargramostim 6 fludarabine 6 Vinblastine 6 Mitoxantrone 6 Methylprednisolone 6 Gemcitabine 6 Chlorambucil 6 Antilymphocyte Serum 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lymphoma × Blood Specimen Collection × Clear all

NCT03985696 2022-07-25

ExoReBLy

University Hospital, Limoges

Phase NA Unknown

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡